On September 1, 2022 Ascendis Pharma A/S (Nasdaq: ASND) reported that the company is scheduled to participate in three upcoming investor conferences in September (Press release, Ascendis Pharma, SEP 1, 2022, View Source [SID1234618893]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details:

Event Citi’s 17th Annual BioPharma Conference
Location Boston, MA
Date Wednesday, September 7, 2022
Time 3:30-4:15 p.m. Eastern Time / 12:30-1:15 p.m. Pacific Time
Speaker(s) Scott Smith, Senior Vice President, Chief Financial Officer

Event 2022 Wells Fargo Healthcare Conference
Location Boston, MA
Date Thursday, September 8, 2022
Time 8:35-9:05 a.m. Eastern Time / 5:35-6:05 a.m. Pacific Time
Speaker(s) Scott Smith, Senior Vice President, Chief Financial Officer

Event Morgan Stanley 20th Annual Global Healthcare Conference
Location New York, NY
Date Tuesday, September 13, 2022
Time 1:30-2:00 p.m. Eastern Time / 10:30-11:00 a.m. Pacific Time
Speaker(s) Jan Mikkelsen, President and Chief Executive Officer and Scott Smith, Senior Vice President, Chief Financial Officer
A live webcast of the events will be available on the Investors & News section of the Ascendis Pharma website at View Source A webcast replay will also be available on this website shortly after conclusion of each event for 30 days.